PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai\'an, China.\', \'School of Clinical Medicine, Southwest Medical University, Luzhou, China.\', \'Department of Clinical Laboratory, Chongqing General Hospital, Chongqing, China.\', \'Department of Clinical Laboratory, The Fifth People\'s Hospital of Chongqing & Chongqing Renji Hospital, University of Chinese Academy of Sciences, Chongqing, China.\', \'Department of Clinical Laboratory, Chongqing Public Health Medical Center, Chongqing, China.\', \'Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.\', \'Testing Center, Bioyong Technologics, Inc., Beijing, China.\', \'Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.748566
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34630427
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34630427>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34630427>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all